About Us

Diabetes is a disease characterized by abnormally high levels of blood glucose and inadequate levels of insulin. Glucose is a simple sugar used by all the cells of the body to produce energy and support life.

Humans need a minimum level of glucose in their blood at all times to function and stay alive. Insulin is a peptide hormone naturally secreted by the pancreas to regulate the body's management of glucose.

When a healthy individual begins a meal, the pancreas releases a natural spike of insulin, called the first-phase insulin release, which is critical to the body's overall control of glucose.

Many patients with diabetes lack the first-phase insulin release and must treat themselves with daily meal-time insulin injections to avoid the negative effects of hyperglycemia and hypoglycemia.

Overview

At Biodel, we believe patients deserve better medicines to treat diabetes and its complications. Our goal is to design, develop and advance safe and effective medicines that make it easier for patients to manage their disease successfully.

By combining our proprietary drug-delivery technology and unique expertise in diabetes drug development, we are working aggressively to meet this goal.

Our Products

Biodel is developing novel forms of insulin and other peptide hormones for use in treating diabetes and its complications, including hyperglycemia, hypoglycemia, cardiovascular complications and weight control.

Our Pipeline

We are building a pipeline of insulin- and other peptide hormone-based product candidates and companion products using our proprietary technology, scientific knowledge and clinical expertise in diabetes drug development.